|
|
 |
|
Viewing report
|
|
|
|
Asthma: KOL Insights on Treatment Practices and Unmet Needs
Sociable Pharma, Oct 2011, Pages: 92
In-depth primary research was conducted in the US and across Europe with six key opinion leaders to understand how changes will impact therapy use in the future. During the European Respiratory Society's 2011 Annual Congress, opinion was gauged on the impact that new clinical data for existing and pipeline products will have on treatment strategies employed by asthma specialists.
Understand key treatment trends based on the latest KOL insights, including:
- Step-up and step-down approaches to asthma treatment
- Tiotropium: an emerging therapy
- Immunotherapy: the hope for more comprehensive treatment
- Combination of inhaled corticosteroids and LABA therapy: current and future trends
Identify unmet needs, including:
- Managing patients with severe persistent asthma
- Optimizing inhaled corticosteroid therapy
- Initiating omalizumab therapy
- LTRA therapy for Step 2 – mild persistent asthma
Key features:
- 2 treatment maps & 8 treatment settings: A visual guide to the treatment of asthma, based on extensive primary and secondary research
- Analysis of current US/EU treatment practices involving 8 drug classes: Inhaled short-acting ß2 agonist, inhaled corticosteroids, inhaled long-acting ß2 agonist, combination inhaler of ICS + LABA, leukotriene receptor antagonists, methylxanthines, oral corticosteroids, anti IgE monoclonal anGbodies
- 6 unmet needs identified: Based on KOL interviews and literature research
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
